Menu
GWAS Study

Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21.

Ostrom QT, Kinnersley B, Wrensch MR et al.

29743610 PubMed ID
GWAS Study Type
18723 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

OQ
Ostrom QT
KB
Kinnersley B
WM
Wrensch MR
EJ
Eckel-Passow JE
AG
Armstrong G
RT
Rice T
CY
Chen Y
WJ
Wiencke JK
ML
McCoy LS
HH
Hansen HM
AC
Amos CI
BJ
Bernstein JL
CE
Claus EB
ID
Il'yasova D
JC
Johansen C
LD
Lachance DH
LR
Lai RK
MR
Merrell RT
OS
Olson SH
SS
Sadetzki S
SJ
Schildkraut JM
SS
Shete S
RJ
Rubin JB
LJ
Lathia JD
BM
Berens ME
AU
Andersson U
RP
Rajaraman P
CS
Chanock SJ
LM
Linet MS
WZ
Wang Z
YM
Yeager M
HR
Houlston RS
JR
Jenkins RB
MB
Melin B
BM
Bondy ML
BJ
Barnholtz-Sloan JS
Chapter II

Abstract

Summary of the research findings

Incidence of glioma is approximately 50% higher in males. Previous analyses have examined exposures related to sex hormones in women as potential protective factors for these tumors, with inconsistent results. Previous glioma genome-wide association studies (GWAS) have not stratified by sex. Potential sex-specific genetic effects were assessed in autosomal SNPs and sex chromosome variants for all glioma, GBM and non-GBM patients using data from four previous glioma GWAS. Datasets were analyzed using sex-stratified logistic regression models and combined using meta-analysis. There were 4,831 male cases, 5,216 male controls, 3,206 female cases and 5,470 female controls. A significant association was detected at rs11979158 (7p11.2) in males only. Association at rs55705857 (8q24.21) was stronger in females than in males. A large region on 3p21.31 was identified with significant association in females only. The identified differences in effect of risk variants do not fully explain the observed incidence difference in glioma by sex.

4,831 European ancestry male cases, 3,206 European ancestry female cases, 5,216 European ancestry male controls, 5,470 European ancestry female controls

Chapter III

Study Statistics

Key metrics and study information

18723
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.